KPV (Lys-Pro-Val)

Technical Overview

KPV is a naturally occurring tripeptide (Lysine-Proline-Valine) derived from the C-terminal fragment of Alpha-Melanocyte-Stimulating Hormone (α-MSH). It is a potent anti-inflammatory agent that targets cellular inflammation pathways without the pigment-inducing effects of its parent hormone.

⏱️ Pharmacokinetics

Parameter	Value	Notes
Half-life	~30 Minutes	Rapidly degraded if not encapsulated
Tmax	20 - 30 Minutes	Peak levels after SubQ or oral dosing (via PepT1)
Biological Window	4 - 6 Hours	Downstream NF-κB inhibition lasts several hours

Mechanism of Action

• NF-κB Inhibition: Directly inhibits the nuclear factor kappa B (NF-κB) signaling pathway, reducing the production of pro-inflammatory cytokines like IL-1β, IL-6, and TNF-α [PMID: 40073467].
• PepT1 Transporter: KPV is actively transported into cells (especially in the colon and skin) via the PepT1 transporter. In inflammatory states like IBD, the body naturally upregulates PepT1, making KPV's delivery "inflammation-targeted" [PMID: 18061177].
• Pyroptosis Prevention: 2025 research shows KPV mitigates keratinocyte (skin cell) death (pyroptosis) caused by fine particulate matter and environmental pollutants [PMID: 40073467].

---

‍ Layman's Explanation

KPV is your body's "Fire Extinguisher." While other hormones might try to "command" your immune system to stop fighting, KPV just walks into the "fire" (the inflamed cell) and smothers it directly. It uses a special "back door" (the PepT1 transporter) that only opens wide when a cell is actually on fire. This makes it incredibly effective at calming down an angry gut (like in Colitis) or angry skin (like in Psoriasis) without affecting the rest of the building.

---

️ Demographic Warnings & Precautions

️ Obesity & Metabolic State

Adipose-Driven Inflammation. Obesity creates a state of chronic TNF-alpha secretion from fat tissue. KPV is specifically indicated for neutralizing this TNF-alpha-driven "metabolic fire" but may require higher dosages due to the volume of inflamed adipose tissue.

Elderly (Advanced Age)

Gut Barrier Support. Sarcopenia and aging are often linked to "Leaky Gut." KPV supports the mucosal integrity of the intestines, potentially improving nutrient absorption and reducing "inflammaging" (age-related systemic inflammation) [PMID: 18061177].

️ Heart & Cardiovascular Conditions

Endothelial Protection. By inhibiting NF-κB in the blood vessel walls (endothelium), KPV may help prevent the plaque buildup (atherosclerosis) caused by chronic inflammation. It is generally safe for heart patients as it has no known effect on blood pressure or heart rate.

---

Upsides & Downsides

Upsides

• Inflammation-Targeted: Naturally moves towards inflamed tissue via upregulated transporters.
• Non-Melanogenic: Unlike α-MSH, it will NOT darken the skin or hair.
• Oral Bioavailability: Highly effective when taken orally, especially for gut health.

Downsides

• High Degradation: In its pure form, it is very fragile; usually requires specific formulations (like acetate salts) for stability.
• Limited Repair: Primarily stops the "fire" (inflammation) but does not necessarily drive the "rebuilding" (growth hormone pathways).

---

Synergies

• BPC-157: The ultimate gut-repair stack. KPV stops the inflammation (the "fire"), while BPC-157 builds the new tissue (the "construction").
• Alpha-GPC: May enhance the cholinergic anti-inflammatory pathway, complementing KPV's direct NF-κB inhibition.
• Antioxidants (e.g., Vitamin C): Synergizes to reduce ROS-mediated cell death (pyroptosis) [PMID: 40073467].

---

Key References

• [PMID: 40073467] - Sung J, et al. KPV mitigates keratinocyte apoptosis and inflammation (2025).
• [PMID: 18061177] - KPV, a tripeptide in the treatment of intestinal inflammation (2007).
• [PMID: 28343991] - Iontophoretic and microneedle-mediated transdermal delivery of KPV (2017).
• [PMID: 12750433] - Anti-inflammatory effects of the tripeptide Lys-Pro-Val (2003).